| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Liliana López-Kleine | |
| Adriana Rojas | |||
| Berta Henríquez | |||
| Beatriz Andrea Otálora-Otálora | |||
| P2860 | cites work | Hallmarks of Cancer: The Next Generation | Q22252312 |
| Structural basis for the heterodimeric interaction between the acute leukaemia-associated transcription factors AML1 and CBFbeta | Q22254263 | ||
| MOZ and MORF histone acetyltransferases interact with the Runt-domain transcription factor Runx2 | Q24294814 | ||
| Src kinase phosphorylates RUNX3 at tyrosine residues and localizes the protein in the cytoplasm | Q24297348 | ||
| Roles of HIPK1 and HIPK2 in AML1- and p300-dependent transcription, hematopoiesis and blood vessel formation | Q24300183 | ||
| Isoforms of the Ets transcription factor NERF/ELF-2 physically interact with AML1 and mediate opposing effects on AML1-mediated transcription of the B cell-specific blk gene | Q24309536 | ||
| RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis | Q24310469 | ||
| AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization | Q24311698 | ||
| Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia | Q24319864 | ||
| Cloning, mapping and expression of PEBP2 alpha C, a third gene encoding the mammalian Runt domain | Q24319877 | ||
| The Hallmarks of Cancer | Q221226 | ||
| Proviral insertion indicates a dominant oncogenic role for Runx1/AML-1 in T-cell lymphoma. | Q54798575 | ||
| The Runt domain identifies a new family of heteromeric transcriptional regulators. | Q55066074 | ||
| Expression levels of the runt-related transcription factor 1 and 3 genes in the development of acute myeloid leukemia. | Q55355645 | ||
| Canonical WNT Signaling Promotes Osteogenesis by Directly StimulatingRunx2Gene Expression | Q57129723 | ||
| Architecture and anatomy of the genomic locus encoding the human leukemia-associated transcription factor RUNX1/AML1 | Q57338760 | ||
| TLE, the Human Homolog of Groucho, Interacts with AML1 and Acts as a Repressor of AML1-Induced Transactivation | Q57662520 | ||
| Genetic compensation of RUNX family transcription factors in leukemia | Q58699333 | ||
| RUNX1 amplification in AML with myelodysplasia-related changes and ring 21 chromosomes | Q64048554 | ||
| AML1 gene amplification: a novel finding in childhood acute lymphoblastic leukemia | Q73651964 | ||
| Runx2: a novel oncogenic effector revealed by in vivo complementation and retroviral tagging | Q73787472 | ||
| Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2alphaB gene associated with myeloblastic leukemias | Q74587955 | ||
| Enforced expression of Runx2 perturbs T cell development at a stage coincident with beta-selection | Q74754525 | ||
| Runx3 is required for the specification of TrkC-expressing mechanoreceptive trigeminal ganglion neurons | Q82338501 | ||
| Helicobacter pylori causes runx3 gene methylation and its loss of expression in gastric epithelial cells, which is mediated by nitric oxide produced by macrophages | Q84372860 | ||
| Functional relationship between p53 and RUNX proteins | Q90392099 | ||
| Glycemic Variability Promotes Both Local Invasion and Metastatic Colonization by Pancreatic Ductal Adenocarcinoma | Q91792797 | ||
| Runx3 inactivation is a crucial early event in the development of lung adenocarcinoma | Q24339585 | ||
| Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21(CIP1/WAF1) promoter | Q24537942 | ||
| Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia | Q24596770 | ||
| Alternative splicing and genomic structure of theAML1gene involved in acute myeloid leukemia | Q24626212 | ||
| Modulation of Runx2 activity by estrogen receptor-alpha: implications for osteoporosis and breast cancer | Q24654971 | ||
| The evolution of Runx genes I. A comparative study of sequences from phylogenetically diverse model organisms | Q24792586 | ||
| CBFbeta is a facultative Runx partner in the sea urchin embryo | Q25255704 | ||
| RUNX2 and the PI3K/AKT axis reciprocal activation as a driving force for tumor progression | Q26800112 | ||
| Activated Notch1 target genes during embryonic cell differentiation depend on the cellular context and include lineage determinants and inhibitors | Q27324100 | ||
| Immunoglobulin motif DNA recognition and heterodimerization of the PEBP2/CBF Runt domain | Q27619000 | ||
| Structural analyses of DNA recognition by the AML1/Runx-1 Runt domain and its allosteric control by CBFbeta | Q27630690 | ||
| Regulation of Estrogen Receptor α by the SET7 Lysine Methyltransferase | Q27650581 | ||
| Physical interaction of the activator protein-1 factors c-Fos and c-Jun with Cbfa1 for collagenase-3 promoter activation | Q28201036 | ||
| Osteoblast-related transcription factors Runx2 (Cbfa1/AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells | Q28204395 | ||
| Histone deacetylase activity is required for full transcriptional repression by mSin3A | Q28238079 | ||
| Control of RUNX2 isoform expression: the role of promoters and enhancers | Q28245927 | ||
| The RUNX genes: gain or loss of function in cancer | Q28247901 | ||
| TGFbeta and Wnt pathway cross-talk | Q28248305 | ||
| Regulatory controls for osteoblast growth and differentiation: role of Runx/Cbfa/AML factors | Q28258100 | ||
| Whole-genome analysis informs breast cancer response to aromatase inhibition | Q28269291 | ||
| The immunoglobulin superfamily--domains for cell surface recognition | Q28294978 | ||
| AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia | Q28304079 | ||
| Dimerization with PEBP2beta protects RUNX1/AML1 from ubiquitin-proteasome-mediated degradation | Q28348865 | ||
| RUNX3 has an oncogenic role in head and neck cancer | Q28475605 | ||
| Causal relationship between the loss of RUNX3 expression and gastric cancer | Q28509530 | ||
| Generation and reproductive phenotypes of mice lacking estrogen receptor beta | Q28513765 | ||
| Conservation and expression of an alternative 3' exon of Runx2 encoding a novel proline-rich C-terminal domain | Q28588614 | ||
| Runx1 modulates adult hair follicle stem cell emergence and maintenance from distinct embryonic skin compartments | Q28590882 | ||
| Runx3 controls the axonal projection of proprioceptive dorsal root ganglion neurons | Q28591148 | ||
| The evolutionary origin of the Runx/CBFbeta transcription factors--studies of the most basal metazoans | Q28757287 | ||
| Epigenetics in cancer | Q29617139 | ||
| Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers | Q30276341 | ||
| Runx transcription factors and the developmental balance between cell proliferation and differentiation. | Q30332928 | ||
| Runx1/AML1 in normal and abnormal hematopoiesis. | Q30351255 | ||
| The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion | Q30447945 | ||
| An ensemble of regulatory elements controls Runx3 spatiotemporal expression in subsets of dorsal root ganglia proprioceptive neurons | Q30833502 | ||
| PEBP2-beta/CBF-beta-dependent phosphorylation of RUNX1 and p300 by HIPK2: implications for leukemogenesis | Q32884406 | ||
| Pim-1 kinase phosphorylates RUNX family transcription factors and enhances their activity | Q33242887 | ||
| Lack of RUNX3 regulation in human gastric cancer | Q33254397 | ||
| Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia | Q33330210 | ||
| Expression analysis of genes associated with human osteosarcoma tumors shows correlation of RUNX2 overexpression with poor response to chemotherapy | Q33577472 | ||
| Definitive hematopoiesis requires Runx1 C-terminal-mediated subnuclear targeting and transactivation. | Q33697682 | ||
| Groucho/TLE/R-esp proteins associate with the nuclear matrix and repress RUNX (CBF(alpha)/AML/PEBP2(alpha)) dependent activation of tissue-specific gene transcription | Q33902979 | ||
| The bone-specific expression of Runx2 oscillates during the cell cycle to support a G1-related antiproliferative function in osteoblasts | Q33953806 | ||
| Transcription-coupled translation control of AML1/RUNX1 is mediated by cap- and internal ribosome entry site-dependent mechanisms. | Q33962440 | ||
| runt homology domain transcription factors (Runx, Cbfa, and AML) mediate repression of the bone sialoprotein promoter: evidence for promoter context-dependent activity of Cbfa proteins | Q33967954 | ||
| Transcriptional regulation of early B-lymphocyte differentiation | Q33996239 | ||
| Notch signaling: the core pathway and its posttranslational regulation | Q34017623 | ||
| Osteomimicry: how tumor cells try to deceive the bone | Q34022631 | ||
| Sequence analysis of mutations and translocations across breast cancer subtypes | Q34032470 | ||
| RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD. | Q34042783 | ||
| The RUNX3 gene--sequence, structure and regulated expression | Q34104024 | ||
| Absence of Runx3 expression in normal gastrointestinal epithelium calls into question its tumour suppressor function | Q34203284 | ||
| Defining a tissue stem cell-driven Runx1/Stat3 signalling axis in epithelial cancer. | Q34303695 | ||
| The Role of RUNX2 in Osteosarcoma Oncogenesis | Q34423871 | ||
| Expression pattern, regulation, and biological role of runt domain transcription factor, run, in Caenorhabditis elegans | Q34440372 | ||
| Hematopoietic stem cell fate is established by the Notch-Runx pathway | Q34451310 | ||
| Tackling the cancer stem cells - what challenges do they pose? | Q34523263 | ||
| Frequent attenuation of the WWOX tumor suppressor in osteosarcoma is associated with increased tumorigenicity and aberrant RUNX2 expression | Q34570006 | ||
| The human SWI/SNF complex associates with RUNX1 to control transcription of hematopoietic target genes | Q34606841 | ||
| A continuum model for tumour suppression | Q34631552 | ||
| Notch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application | Q34712645 | ||
| The RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells undergoing transforming growth factor beta-induced apoptosis | Q34718167 | ||
| Core-binding factors in haematopoiesis and leukaemia | Q34718183 | ||
| Transcription factors as targets for cancer therapy | Q34932264 | ||
| Cancer-related ectopic expression of the bone-related transcription factor RUNX2 in non-osseous metastatic tumor cells is linked to cell proliferation and motility | Q34989177 | ||
| A role for RUNX3 in inflammation-induced expression of IL23A in gastric epithelial cells. | Q35018677 | ||
| Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression | Q35779750 | ||
| Regulation of breast cancer metastasis by Runx2 and estrogen signaling: the role of SNAI2. | Q35889648 | ||
| Tumor suppressor function of RUNX3 in breast cancer | Q35914643 | ||
| Runx2 mediates epigenetic silencing of the bone morphogenetic protein-3B (BMP-3B/GDF10) in lung cancer cells | Q36040069 | ||
| Specificity of Genetic Biomarker Studies in Cancer Research: A Systematic Review. | Q36068850 | ||
| Molecular mechanisms of cooperative binding of transcription factors Runx1-CBFβ-Ets1 on the TCRα gene enhancer | Q36288656 | ||
| Runx2 deficiency and defective subnuclear targeting bypass senescence to promote immortalization and tumorigenic potential. | Q36288903 | ||
| The RUNX Genes as Conditional Oncogenes: Insights from Retroviral Targeting and Mouse Models | Q36309953 | ||
| Targeting Transcription Factors in Cancer | Q36347511 | ||
| Runx1: no longer just for leukemia | Q36382122 | ||
| Runx3 controls growth and differentiation of gastric epithelial cells in mammals | Q36390962 | ||
| Proviral insertions induce the expression of bone-specific isoforms of PEBP2alphaA (CBFA1): evidence for a new myc collaborating oncogene | Q36552332 | ||
| The extracellular signal-regulated kinase pathway phosphorylates AML1, an acute myeloid leukemia gene product, and potentially regulates its transactivation ability | Q36561099 | ||
| Groucho-dependent and -independent repression activities of Runt domain proteins | Q36572515 | ||
| Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone. | Q36682092 | ||
| Enhancer of zeste homologue 2 (EZH2) down-regulates RUNX3 by increasing histone H3 methylation | Q36719239 | ||
| RUNX1 permits E4orf6-directed nuclear localization of the adenovirus E1B-55K protein and associates with centers of viral DNA and RNA synthesis | Q36747955 | ||
| Estrogen receptor-alpha hinge-region lysines 302 and 303 regulate receptor degradation by the proteasome | Q36756461 | ||
| Discriminating gene expression profiles of memory B cell subpopulations. | Q36851928 | ||
| RUNX3 acts as a tumor suppressor in breast cancer by targeting estrogen receptor α | Q36971996 | ||
| RUNX3 defines disease behavior in pancreatic ductal adenocarcinoma | Q36998003 | ||
| Oncogene-induced senescence: an essential role for Runx | Q37234252 | ||
| Parathyroid hormone/parathyroid hormone-related peptide regulate osteosarcoma cell functions: Focus on the extracellular matrix (Review). | Q37255459 | ||
| DNA methylation of Runx1 regulatory regions correlates with transition from primitive to definitive hematopoietic potential in vitro and in vivo | Q37263155 | ||
| Wnt signaling from development to disease: insights from model systems | Q37342306 | ||
| RUNX1 translocations in malignant hemopathies | Q37469621 | ||
| Post-translational Regulation of Runx2 in Bone and Cartilage | Q37592911 | ||
| Transcription factor Runx3 regulates interleukin-15-dependent natural killer cell activation | Q37643938 | ||
| The role of chromosome 21 in hematology and oncology | Q37709977 | ||
| RUNX3 is multifunctional in carcinogenesis of multiple solid tumors | Q37720402 | ||
| Runx2 in normal tissues and cancer cells: A developing story. | Q37767879 | ||
| New insights into the inactivation of gastric tumor suppressor RUNX3: the role of H. pylori infection | Q37832453 | ||
| Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes | Q37849461 | ||
| The RUNX family in breast cancer: relationships with estrogen signaling | Q38050410 | ||
| Context-dependent activation of Wnt signaling by tumor suppressor RUNX3 in gastric cancer cells | Q35051435 | ||
| The Runx genes as dominant oncogenes | Q35121742 | ||
| Requisite roles of Runx2 and Cbfb in skeletal development | Q35156615 | ||
| Loss of osteoblast Runx3 produces severe congenital osteopenia | Q35165153 | ||
| Multiple signaling pathways converge on the Cbfa1/Runx2 transcription factor to regulate osteoblast differentiation | Q35210378 | ||
| Temporal and spatial parameters of skeletal gene expression: targeting RUNX factors and their coregulatory proteins to subnuclear domains | Q35210386 | ||
| Lineage-specific RUNX3 hypomethylation marks the preneoplastic immune component of gastric cancer. | Q35463668 | ||
| The corepressor mSin3A regulates phosphorylation-induced activation, intranuclear location, and stability of AML1. | Q35544219 | ||
| Runx2/Cbfa1: A Multifunctional Regulator of Bone Formation | Q35552258 | ||
| Retroviral insertional mutagenesis identifies RUNX genes involved in chronic myeloid leukemia disease persistence under imatinib treatment | Q35663526 | ||
| RUNX3 Controls a Metastatic Switch in Pancreatic Ductal Adenocarcinoma | Q35690596 | ||
| Oncogenic potential of the RUNX gene family: 'overview'. | Q35779678 | ||
| Structure and regulated expression of mammalian RUNX genes | Q35779684 | ||
| Role of RUNX family members in transcriptional repression and gene silencing | Q35779689 | ||
| Role of the TEL-AML1 fusion gene in the molecular pathogenesis of childhood acute lymphoblastic leukaemia | Q35779725 | ||
| Point mutations in the RUNX1/AML1 gene: another actor in RUNX leukemia | Q35779731 | ||
| The Runx genes: lineage-specific oncogenes and tumor suppressors | Q35779743 | ||
| RUNX family: Regulation and diversification of roles through interacting proteins | Q38062515 | ||
| Targeting transcription factors: promising new strategies for cancer therapy | Q38139175 | ||
| Runx2 regulates G protein-coupled signaling pathways to control growth of osteoblast progenitors | Q38289269 | ||
| Expression of transcription factor AML-2 (RUNX3, CBF(alpha)-3) is induced by Epstein-Barr virus EBNA-2 and correlates with the B-cell activation phenotype | Q38289967 | ||
| Gene array analysis reveals a common Runx transcriptional programme controlling cell adhesion and survival | Q38289974 | ||
| Requirement of Runx1/AML1/PEBP2alphaB for the generation of haematopoietic cells from endothelial cells | Q38304430 | ||
| Runx3 regulates dendritic epidermal T cell development | Q38305806 | ||
| The RUNX family: developmental regulators in cancer | Q38319972 | ||
| Regulation of RUNX2 transcription factor-DNA interactions and cell proliferation by vitamin D3 (cholecalciferol) prohormone activity | Q38329289 | ||
| Runx3 at the interface of immunity, inflammation and cancer | Q38340309 | ||
| RUNX2 and Osteosarcoma | Q38367587 | ||
| Frequent amplification and rearrangement of chromosomal bands 6p12-p21 and 17p11.2 in osteosarcoma | Q38481726 | ||
| Inhibition of Notch1 signaling by Runx2 during osteoblast differentiation. | Q38482269 | ||
| Focus on the p38 MAPK signaling pathway in bone development and maintenance | Q38541335 | ||
| The emerging role of RUNX3 in cancer metastasis (Review). | Q38680772 | ||
| RUNX super-enhancer control through the Notch pathway by Epstein-Barr virus transcription factors regulates B cell growth. | Q38793717 | ||
| Epigenetic Control of the Bone-master Runx2 Gene during Osteoblast-lineage Commitment by the Histone Demethylase JARID1B/KDM5B. | Q38829110 | ||
| Runx3 in Immunity, Inflammation and Cancer | Q38904246 | ||
| Association of polyalanine and polyglutamine coiled coils mediates expansion disease-related protein aggregation and dysfunction | Q39027090 | ||
| Runx transcription factors in the development and function of the definitive hematopoietic system | Q39127010 | ||
| Role of RUNX1 in hematological malignancies | Q39127024 | ||
| Runx3 protects gastric epithelial cells against epithelial-mesenchymal transition-induced cellular plasticity and tumorigenicity | Q39296192 | ||
| Transcription factor Runx2 is a regulator of epithelial-mesenchymal transition and invasion in thyroid carcinomas | Q39340986 | ||
| Runt-related transcription factor 3 reverses epithelial-mesenchymal transition in hepatocellular carcinoma | Q39367341 | ||
| Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO. | Q39576827 | ||
| C/EBPβ binds the P1 promoter of the Runx2 gene and up-regulates Runx2 transcription in osteoblastic cells | Q39596135 | ||
| RUNX3 maintains the mesenchymal phenotype after termination of the Notch signal | Q39598984 | ||
| Runx2 regulates survivin expression in prostate cancer cells | Q39769098 | ||
| Pim-1 kinase phosphorylates and stabilizes RUNX3 and alters its subcellular localization. | Q39944141 | ||
| Expression and function of Cbfa-1/Runx2 in thyroid papillary carcinoma cells | Q39996177 | ||
| Differential regulation of estrogen receptor alpha turnover and transactivation by Mdm2 and stress-inducing agents | Q40124566 | ||
| AML1/Runx1 rescues Notch1-null mutation-induced deficiency of para-aortic splanchnopleural hematopoiesis | Q40247755 | ||
| RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer | Q40259898 | ||
| The transcriptionally active form of AML1 is required for hematopoietic rescue of the AML1-deficient embryonic para-aortic splanchnopleural (P-Sp) region | Q40532293 | ||
| Fidelity of Runx2 activity in breast cancer cells is required for the generation of metastases-associated osteolytic disease. | Q40539678 | ||
| Transcriptional regulation of T-cell genes during T-cell development | Q40623651 | ||
| IRES-dependent translational control of Cbfa1/Runx2 expression. | Q40676811 | ||
| Oncogenic transcription factors in the human acute leukemias | Q41628889 | ||
| Genetic regulation of the RUNX transcription factor family has antitumor effects | Q41661754 | ||
| Priming of lineage-specifying genes by Bcl11b is required for lineage choice in post-selection thymocytes. | Q41676561 | ||
| Characterization of CADD522, a small molecule that inhibits RUNX2-DNA binding and exhibits antitumor activity | Q42378493 | ||
| CHIP (carboxyl terminus of Hsc70-interacting protein) promotes basal and geldanamycin-induced degradation of estrogen receptor-alpha | Q42481557 | ||
| The vitamin D receptor, Runx2, and the Notch signaling pathway cooperate in the transcriptional regulation of osteopontin | Q42484713 | ||
| A specific targeting signal directs Runx2/Cbfa1 to subnuclear domains and contributes to transactivation of the osteocalcin gene | Q42511041 | ||
| Developmental-stage-dependent transcriptional response to leukaemic oncogene expression. | Q42602670 | ||
| Runx2 mRNA expression in the tissue, serum, and circulating non-hematopoietic cells of patients with thyroid cancer | Q42644602 | ||
| Runx2 disruption promotes immortalization and confers resistance to oncogene-induced senescence in primary murine fibroblasts | Q42819809 | ||
| Alternative RUNX1 Promoter Regulation by Wnt/β-Catenin Signaling in Leukemia Cells and Human Hematopoietic Progenitors. | Q45345502 | ||
| Roles of VWRPY motif-mediated gene repression by Runx proteins during T-cell development | Q46165523 | ||
| TNF-alpha's effects on proliferation and apoptosis in human mesenchymal stem cells depend on RUNX2 expression | Q46214032 | ||
| RUNX1: A Regulator of NF-kB Signaling in Pulmonary Diseases | Q47678907 | ||
| TGFβ Promotes Genomic Instability after Loss of RUNX3. | Q47709830 | ||
| Polycomb group ring finger 1 cooperates with Runx1 in regulating differentiation and self-renewal of hematopoietic cells. | Q48027800 | ||
| Emerging role of RUNX3 in the regulation of tumor microenvironment. | Q50077138 | ||
| RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization. | Q50335772 | ||
| Cell growth regulatory role of Runx2 during proliferative expansion of preosteoblasts | Q51017945 | ||
| RUNX3 and p53: How Two Tumor Suppressors Cooperate Against Oncogenic Ras? | Q51097612 | ||
| Shared and distinct roles mediated through C-terminal subdomains of acute myeloid leukemia/Runt-related transcription factor molecules in murine development. | Q51540139 | ||
| Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. | Q52111650 | ||
| Transcription factors RUNX1/AML1 and RUNX2/Cbfa1 dynamically associate with stationary subnuclear domains. | Q52114278 | ||
| Increased expression of AML1 during retinoic-acid-induced differentiation of U937 cells. | Q52508473 | ||
| RUNX1 positively regulates the ErbB2/HER2 signaling pathway through modulating SOS1 expression in gastric cancer cells. | Q52568539 | ||
| Mastermind is a putative activator for Notch. | Q52580782 | ||
| Mechanical stress-mediated Runx2 activation is dependent on Ras/ERK1/2 MAPK signaling in osteoblasts. | Q53574018 | ||
| Wnt induction of chondrocyte hypertrophy through the Runx2 transcription factor. | Q54611050 | ||
| Runx2 in human breast carcinoma: its potential roles in cancer progression | Q54643065 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivatives | Q6937225 |
| P433 | issue | 1 | |
| P921 | main subject | neoplasm | Q1216998 |
| P304 | page(s) | 3-19 | |
| P577 | publication date | 2019-05-06 | |
| 2019-07-01 | |||
| P1433 | published in | Oncology Reports | Q7092098 |
| P1476 | title | RUNX family: Oncogenes or tumor suppressors (Review). | |
| P478 | volume | 42 |
Search more.